The relaxin receptor (RXFP1) utilizes hydrophobic moieties on a signaling surface of its N-terminal low density lipoprotein class A module to mediate receptor activation.
The peptide hormone relaxin is showing potential as a treatment for acute heart failure. Although it is known that relaxin mediates its actions through the G protein-coupled receptor relaxin family peptide receptor 1 (RXFP1), little is known about the molecular mechanisms by which relaxin binding results in receptor activation. Previous studies have highlighted that the unique N-terminal low density lipoprotein class A (LDLa) module of RXFP1 is essential for receptor activation, and it has been hypothesized that this module is the true "ligand" of the receptor that directs the conformational changes necessary for G protein coupling. In this study, we confirmed that an RXFP1 receptor lacking the LDLa module binds ligand normally but cannot signal through any characterized G protein-coupled receptor signaling pathway. Furthermore, we comprehensively examined the contributions of amino acids in the LDLa module to RXFP1 activity using both gain-of-function and loss-of-function mutational analysis together with NMR structural analysis of recombinant LDLa modules. Gain-of-function studies with an inactive RXFP1 chimera containing the LDLa module of the human LDL receptor (LB2) demonstrated two key N-terminal regions of the module that were able to rescue receptor signaling. Loss-of-function mutations of residues in these regions demonstrated that Leu-7, Tyr-9, and Lys-17 all contributed to the ability of the LDLa module to drive receptor activation, and judicious amino acid substitutions suggested this involves hydrophobic interactions. Our results demonstrate that these key residues contribute to interactions driving the active receptor conformation, providing further evidence of a unique mode of G protein-coupled receptor activation.
From the Florey Institute of Neuroscience and Mental Health and Florey Department of Neuroscience and Mental Health.
Roy C K
RC
Kong
Emma J
EJ
Petrie
Biswaranjan
B
Mohanty
Jason
J
Ling
Jeremy C Y
JC
Lee
Paul R
PR
Gooley
Ross A D
RA
Bathgate
D000469:Alkaline Phosphatase / Q000378:metabolism; D000595:Amino Acid Sequence; D002462:Cell Membrane / Q000378:metabolism; D017930:Genes, Reporter; D057809:HEK293 Cells; D006801:Humans; D057927:Hydrophobic and Hydrophilic Interactions; D009682:Magnetic Resonance Spectroscopy; D008969:Molecular Sequence Data; D010455:Peptides / Q000737:chemistry; D017434:Protein Structure, Tertiary; D043562:Receptors, G-Protein-Coupled / Q000737:chemistry* / Q000235:genetics; D011973:Receptors, LDL / Q000737:chemistry*; D018000:Receptors, Peptide / Q000737:chemistry* / Q000235:genetics; D012065:Relaxin / Q000737:chemistry; D017386:Sequence Homology, Amino Acid; D015398:Signal Transduction
D010455:Peptides; C417543:RXFP1 protein, human; D043562:Receptors, G-Protein-Coupled; D011973:Receptors, LDL; D018000:Receptors, Peptide; D012065:Relaxin; D000469:Alkaline Phosphatase
G Protein-coupled Receptors (GPCR); NMR; Peptide Hormones; Peptides; Protein Structure; RXFP1; Relaxin